Background: Preclinical evidence suggests that progesterone improves recovery after intracerebral hemorrhage (ICH); however, gonadal hormones have sex-specific effects. Therefore, an experimental model of ICH was used to assess recovery after progesterone administration in male and female rats. Methods: ICH was induced in male and female Wistar rats via stereotactic intrastriatal injection of clostridial collagenase (0.5 U). Animals were randomized to receive vehicle or 8 mg/kg progesterone intraperitoneally at 2 h, then subcutaneously at 5, 24, 48, and 72 h after injury. Outcomes included relevant physiology during the first 3 h, hemorrhage and edema evolution over the first 24 h, proinflammatory transcription factor and cytokine regulation at 24 h, rotarod latency and neuroseverity score over the first 7 days, and microglial activation/macrophage recruitment at 7 days after injury. Results: Rotarod latency (p = 0.001) and neuroseverity score (p = 0.01) were improved in progesterone-treated males, but worsened in progesterone-treated females (p = 0.028 and p = 0.008, respectively). Progesterone decreased cerebral edema (p = 0.04), microglial activation/macrophage recruitment (p < 0.001), and proinflammatory transcription factor phosphorylated nuclear factor-κB p65 expression (p = 0.0038) in males but not females, independent of tumor necrosis factor-α, interleukin-6, and toll-like receptor-4 expression. Cerebral perfusion was increased in progesterone-treated males at 4 h (p = 0.043) but not 24 h after injury. Hemorrhage volume, arterial blood gases, glucose, and systolic blood pressure were not affected. Conclusions: Progesterone administration improved early neurobehavioral recovery and decreased secondary neuroinflammation after ICH in male rats. Paradoxically, progesterone worsened neurobehavioral recovery and did not modify neuroinflammation in female rats. Future work should isolate mechanisms of sex-specific progesterone effects after ICH.

Keywords:
Stroke, Progesterone, Neuroinflammation, Cytokines, Rat, Neurobehavioral recovery, Magnetic resonance imaging, Sex difference, Cerebral edema, Intracerebral hemorrhage
1.
Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M; American Heart Association; American Stroke Association Stroke Council; High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working Group: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38:2001-2023.
2.
Feigin VL, Lawes CM, Bennett DA, Anderson CS: Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43-53.
3.
van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ: Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010;9:167-176.
4.
Ishikawa S, Kayaba K, Gotoh T, Nago N, Nakamura Y, Tsutsumi A, Kajii E: Incidence of total stroke, stroke subtypes, and myocardial infarction in the Japanese population: the JMS Cohort Study. J Epidemiol 2008;18:144-150.
5.
Thrift AG, Dewey HM, Sturm JW, Srikanth VK, Gilligan AK, Gall SL, Macdonell RA, McNeil JJ, Donnan GA: Incidence of stroke subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): differences between men and women. Neuroepidemiology 2009;32:11-18.
6.
Tveiten A, Ljostad U, Mygland A, Thomassen L, Pripp AH, Naess H: Intracerebral hemorrhage in southern Norway - a hospital-based incidence study. Eur Neurol 2012;67:240-245.
7.
Vaartjes I, Reitsma JB, Berger-van Sijl M, Bots ML: Gender differences in mortality after hospital admission for stroke. Cerebrovasc Dis 2009;28:564-571.
8.
Wagner I, Volbers B, Kloska S, Doerfler A, Schwab S, Staykov D: Sex differences in perihemorrhagic edema evolution after spontaneous intracerebral hemorrhage. Eur J Neurol 2012;19:1477-1481.
9.
Umeano O, Phillips-Bute B, Hailey CE, Sun W, Gray MC, Roulhac-Wilson B, McDonagh DL, Kranz PG, Laskowitz DT, James ML: Gender and age interact to affect early outcome after intracerebral hemorrhage. PLoS One 2013;8:e81664.
10.
Grossman KJ, Goss CW, Stein DG: Effects of progesterone on the inflammatory response to brain injury in the rat. Brain Res 2004;1008:29-39.
11.
He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG: Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 2004;189:404-412.
12.
Stein DG, Wright DW, Kellermann AL: Does progesterone have neuroprotective properties? Ann Emerg Med 2008;51:164-172.
13.
Pettus EH, Wright DW, Stein DG, Hoffman SW: Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 2005;1049:112-119.
14.
Guo Q, Sayeed I, Baronne LM, Hoffman SW, Guennoun R, Stein DG: Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol 2006;198:469-478.
15.
Roof RL, Duvdevani R, Braswell L, Stein DG: Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 1994;129:64-69.
16.
Wright DW, Bauer ME, Hoffman SW, Stein DG: Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats. J Neurotrauma 2001;18:901-909.
17.
Djebaili M, Guo Q, Pettus EH, Hoffman SW, Stein DG: The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma 2005;22:106-118.
18.
Robertson CL, Puskar A, Hoffman GE, Murphy AZ, Saraswati M, Fiskum G: Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp Neurol 2006;197:235-243.
19.
Sayeed I, Parvez S, Wali B, Siemen D, Stein DG: Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone. Brain Res 2009;1263:165-173.
20.
Roof RL, Hoffman SW, Stein DG: Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol 1997;31:1-11.
21.
Zhang Y, Xiong Y, Mahmood A, Meng Y, Liu Z, Qu C, Chopp M: Sprouting of corticospinal tract axons from the contralateral hemisphere into the denervated side of the spinal cord is associated with functional recovery in adult rat after traumatic brain injury and erythropoietin treatment. Brain Res 2010;1353:249-257.
22.
Guennoun R, Labombarda F, Gonzalez Deniselle MC, Liere P, De Nicola AF, Schumacher M: Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection. J Steroid Biochem Mol Biol 2015;146:48-61.
23.
Ishrat T, Sayeed I, Atif F, Stein DG: Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Res 2009;1257:94-101.
24.
Yousuf S, Sayeed I, Atif F, Tang H, Wang J, Stein DG: Delayed progesterone treatment reduces brain infarction and improves functional outcomes after ischemic stroke: a time-window study in middle-aged rats. J Cereb Blood Flow Metab 2014;34:297-306.
25.
Gibson CL, Constantin D, Prior MJ, Bath PM, Murphy SP: Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol 2005;193:522-530.
26.
Sayeed I, Wali B, Stein DG: Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci 2007;25:151-159.
27.
Gibson CL, Coomber B, Murphy SP: Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice. Brain 2011;134:2125-2133.
28.
Won S, Lee JH, Wali B, Stein DG, Sayeed I: Progesterone attenuates hemorrhagic transformation after delayed TPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway. J Cereb Blood Flow Metab 2014;34:72-80.
29.
Murphy SJ, Littleton-Kearney MT, Hurn PD: Progesterone administration during reperfusion, but not preischemia alone, reduces injury in ovariectomized rats. J Cereb Blood Flow Metab 2002;22:1181-1188.
30.
Ishrat T, Sayeed I, Atif F, Hua F, Stein DG: Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp Neurol 2010;226:183-190.
31.
Gibson CL, Gray LJ, Bath PM, Murphy SP: Progesterone for the treatment of experimental brain injury; a systematic review. Brain 2008;131:318-328.
32.
Kumon Y, Kim SC, Tompkins P, Stevens A, Sakaki S, Loftus CM: Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia. J Neurosurg 2000;92:848-852.
33.
Jiang N, Chopp M, Stein D, Feit H: Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 1996;735:101-107.
34.
Wang J, Jiang C, Liu C, Li X, Chen N, Hao Y: Neuroprotective effects of progesterone following stroke in aged rats. Behav Brain Res 2010;209:119-122.
35.
Chang CM, Su YF, Chang CZ, Chung CL, Tsai YJ, Loh JK, Lin CL: Progesterone attenuates experimental subarachnoid hemorrhage-induced vasospasm by upregulation of endothelial nitric oxide synthase via Akt signaling pathway. Biomed Res Int 2014;2014:207616.
36.
Cai J, Cao S, Chen J, Yan F, Chen G, Dai Y: Progesterone alleviates acute brain injury via reducing apoptosis and oxidative stress in a rat experimental subarachnoid hemorrhage model. Neurosci Lett 2015;600:238-243.
37.
Yan F, Hu Q, Chen J, Wu C, Gu C, Chen G: Progesterone attenuates early brain injury after subarachnoid hemorrhage in rats. Neurosci Lett 2013;543:163-167.
38.
Young AM, Karri SK, Ogilvy CS: Exploring the use of estrogen & progesterone replacement therapy in subarachnoid hemorrhage. Curr Drug Saf 2012;7:202-206.
39.
Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, Gonzalez Deniselle MC, Gonzalez SL, Ibanez C, Labombarda F, Coirini H, Baulieu EE, De Nicola AF: Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res 2004;14(suppl A):S18-S33.
40.
De Nicola AF, Gonzalez Deniselle MC, Garay L, Meyer M, Gargiulo-Monachelli G, Guennoun R, Schumacher M, Carreras MC, Poderoso JJ: Progesterone protective effects in neurodegeneration and neuroinflammation. J Neuroendocrinol 2013;25:1095-1103.
41.
Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, Lauria G, Magnaghi V, Roglio I, Melcangi RC: Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 2007;144:1293-1304.
42.
Chen Z, Xi G, Mao Y, Keep RF, Hua Y: Effects of progesterone and testosterone on ICH-induced brain injury in rats. Acta Neurochir Suppl 2011;111:289-293.
43.
Manaenko A, Chen H, Zhang JH, Tang J: Comparison of different preclinical models of intracerebral hemorrhage. Acta Neurochir Suppl 2011;111:9-14.
44.
Sengupta P: The laboratory rat: relating its age with human's. Int J Prev Med 2013;4:624-630.
45.
Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M: Collagenase-induced intracerebral hemorrhage in rats. Stroke 1990;21:801-807.
46.
Marcondes FK, Bianchi FJ, Tanno AP: Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 2002;62:609-614.
47.
Brown-Grant K, Exley D, Naftolin F: Peripheral plasma oestradiol and luteinizing hormone concentrations during the oestrous cycle of the rat. J Endocrinol 1970;48:295-296.
48.
Miller AE, Riegle GD: Temporal changes in serum progesterone in aging female rats. Endocrinology 1980;106:1579-1583.
49.
Lei B, Sheng H, Wang H, Lascola CD, Warner DS, Laskowitz DT, James ML: Intrastriatal injection of autologous blood or clostridial collagenase as murine models of intracerebral hemorrhage. J Vis Exp 2014;89:e51439.
50.
Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW: The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma 1994;11:187-196.
51.
Sheng SP, Lei B, James ML, Lascola CD, Venkatraman TN, Jung JY, Maze M, Franks NP, Pearlstein RD, Sheng H, Warner DS: Xenon neuroprotection in experimental stroke: interactions with hypothermia and intracerebral hemorrhage. Anesthesiology 2012;117:1262-1275.
52.
Nakamura T, Hua Y, Keep RF, Park JW, Xi G, Hoff JT: Estrogen therapy for experimental intracerebral hemorrhage in rats. J Neurosurg 2005;103:97-103.
53.
Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G: Behavioral tests after intracerebral hemorrhage in the rat. Stroke 2002;33:2478-2484.
54.
James ML, Sullivan PM, Lascola CD, Vitek MP, Laskowitz DT: Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage. Stroke 2009;40:632-639.
55.
Hetier E, Ayala J, Denefle P, Bousseau A, Rouget P, Mallat M, Prochiantz A: Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro. J Neurosci Res 1988;21:391-397.
56.
Askew D, Walker WS: Alloantigen presentation to naive CD8+ T cells by mouse microglia: evidence for a distinct phenotype based on expression of surface-associated and soluble costimulatory molecules. Glia 1996;18:118-128.
57.
Luheshi NM, Rothwell NJ, Brough D: The dynamics and mechanisms of interleukin-1alpha and beta nuclear import. Traffic 2009;10:16-25.
58.
West MJ, Slomianka L, Gundersen HJ: Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991;231:482-497.
59.
Balla DZ, Schwarz S, Wiesner HM, Hennige AM, Pohmann R: Monitoring the stress-level of rats with different types of anesthesia: a tail-artery cannulation protocol. J Pharmacol Toxicol Methods 2014;70:35-39.
60.
Ratilal BO, Arroja MM, Rocha JP, Fernandes AM, Barateiro AP, Brites DM, Pinto RM, Sepodes BM, Mota-Filipe HD: Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion. J Neurosurg 2014;121:55-62.
61.
James ML, Wang H, Venkatraman T, Song P, Lascola CD, Laskowitz DT: Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice. J Neurotrauma 2010;27:217-228.
62.
Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC: The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001;32:891-897.
63.
James ML, Wang H, Cantillana V, Lei B, Kernagis DN, Dawson HN, Klaman LD, Laskowitz DT: TT-301 inhibits microglial activation and improves outcome after central nervous system injury in adult mice. Anesthesiology 2012;116:1299-1311.
64.
Lei B, Mace B, Dawson HN, Warner DS, Laskowitz DT, James ML: Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia. PLoS One 2014;9:e103969.
65.
Lei B, Dawson HN, Roulhac-Wilson B, Wang H, Laskowitz DT, James ML: Tumor necrosis factor alpha antagonism improves neurological recovery in murine intracerebral hemorrhage. J Neuroinflammation 2013;10:103.
66.
Woo D, Haverbusch M, Sekar P, Kissela B, Khoury J, Schneider A, Kleindorfer D, Szaflarski J, Pancioli A, Jauch E, Moomaw C, Sauerbeck L, Gebel J, Broderick J: Effect of untreated hypertension on hemorrhagic stroke. Stroke 2004;35:1703-1708.
67.
Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, Lindley R, Robinson T, Lavados P, Neal B, Hata J, Arima H, Parsons M, Li Y, Wang J, Heritier S, Li Q, Woodward M, Simes RJ, Davis SM, Chalmers J; INTERACT2 Investigators: Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013;368:2355-2365.
68.
Jones NC, Constantin D, Prior MJ, Morris PG, Marsden CA, Murphy S: The neuroprotective effect of progesterone after traumatic brain injury in male mice is independent of both the inflammatory response and growth factor expression. Eur J Neurosci 2005;21:1547-1554.
69.
Wagner AK, Willard LA, Kline AE, Wenger MK, Bolinger BD, Ren D, Zafonte RD, Dixon CE: Evaluation of estrous cycle stage and gender on behavioral outcome after experimental traumatic brain injury. Brain Res 2004;998:113-121.
70.
Cutler SM, Cekic M, Miller DM, Wali B, van Landingham JW, Stein DG: Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma 2007;24:1475-1486.
71.
Subramanian M, Pusphendran CK, Tarachand U, Devasagayam TP: Gestation confers temporary resistance to peroxidation in the maternal rat brain. Neurosci Lett 1993;155:151-154.
72.
Djebaili M, Hoffman SW, Stein DG: Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience 2004;123:349-359.
73.
Chen J, Chopp M, Li Y: Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J Neurol Sci 1999;171:24-30.
74.
Yousuf S, Atif F, Sayeed I, Tang H, Stein DG: Progesterone in transient ischemic stroke: a dose-response study. Psychopharmacology 2014;231:3313-3323.
75.
Candelario-Jalil E, Taheri S, Yang Y, Sood R, Grossetete M, Estrada EY, Fiebich BL, Rosenberg GA: Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat. J Pharmacol Exp Ther 2007;323:488-498.
76.
Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X: Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci Lett 2007;425:177-182.
77.
Lloyd E, Somera-Molina K, Van Eldik LJ, Watterson DM, Wainwright MS: Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J Neuroinflamm 2008;5:28.
78.
Frydenlund DS, Bhardwaj A, Otsuka T, Mylonakou MN, Yasumura T, Davidson KG, Zeynalov E, Skare O, Laake P, Haug FM, Rash JE, Agre P, Ottersen OP, Amiry-Moghaddam M: Temporary loss of perivascular aquaporin-4 in neocortex after transient middle cerebral artery occlusion in mice. Proc Natl Acad Sci USA 2006;103:13532-13536.
79.
Ishrat T, Sayeed I, Atif F, Hua F, Stein DG: Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase b signaling pathway. Neuroscience 2012;210:442-450.
80.
Cai W, Zhu Y, Furuya K, Li Z, Sokabe M, Chen L: Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 2008;55:127-138.
81.
Krause DN, Duckles SP, Pelligrino DA: Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol 2006;101:1252-1261.
82.
Lu GP, Cho E, Marx GF, Gibson J: Cerebral hemodynamic response to female sex hormones in the rat. Microvasc Res 1996;51:393-395.
83.
Murphy SJ, Traystman RJ, Hurn PD, Duckles SP: Progesterone exacerbates striatal stroke injury in progesterone-deficient female animals. Stroke 2000;31:1173-1178.
84.
Bitran D, Shiekh M, McLeod M: Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J Neuroendocrinol 1995;7:171-177.
85.
Schumacher M, Mattern C, Ghoumari A, Oudinet JP, Liere P, Labombarda F, Sitruk-Ware R, De Nicola AF, Guennoun R: Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog Neurobiol 2014;113:6-39.
86.
Aguirre CC, Baudry M: Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices. Eur J Neurosci 2009;29:447-454.
87.
Aguirre C, Jayaraman A, Pike C, Baudry M: Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-beta. J Neurochem 2010;115:1277-1287.
88.
Li Y, Raaby KF, Sanchez C, Gulinello M: Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats. Behav Brain Res 2013;256:520-528.
89.
Toung TJ, Chen TY, Littleton-Kearney MT, Hurn PD, Murphy SJ: Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J Cereb Blood Flow Metab 2004;24:1160-1166.
90.
Baudry M, Bi X, Aguirre C: Progesterone-estrogen interactions in synaptic plasticity and neuroprotection. Neuroscience 2013;239:280-294.
91.
Chisholm NC, Sohrabji F: Astrocytic response to cerebral ischemia is influenced by sex differences and impaired by aging. Neurobiol Dis 2015, Epub ahead of print.
92.
Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein FC, Caveney AF, Howlett-Smith H, Bengelink EM, Manley GT, Merck LH, Janis LS, Barsan WG; NETT Investigators: Very early administration of progesterone for acute traumatic brain injury. N Engl J Med 2014;371:2457-2466.
93.
Roof RL, Duvdevani R, Stein DG: Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor Neurol Neurosci 1992;4:425-427.
94.
Goss CW, Hoffman SW, Stein DG: Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study. Pharmacol Biochem Behav 2003;76:231-242.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.